In addition, previous findings demonstrated that CCAT2 is upregulated in breast tumors; indeed, CCAT2 silencing decreases cell proliferation and invasion in vitro through the Wnt/β-catenin signaling pathway [25]. This evidence concerns the gene CCAT2 and breast neoplasm.